Literature DB >> 3706734

A sensitive assay of GTP cyclohydrolase I activity in rat and human tissues using radioimmunoassay of neopterin.

M Sawada, T Horikoshi, M Masada, M Akino, T Sugimoto, S Matsuura, T Nagatsu.   

Abstract

A highly sensitive and simple assay for the activity of GTP cyclohydrolase I (EC 3.5.4.16) was established using a newly developed radioimmunoassay. D-erythro-7,8-Dihydroneopterin triphosphate formed from GTP by GTP cyclohydrolase I was oxidized by iodine and dephosphorylated by alkaline phosphatase to D-erythro-neopterin, and quantified by a radioimmunoassay for D-erythro-neopterin. This method was highly sensitive and required only 0.2 mg of rat liver tissues for the measurement of the activity. It was reproducible and can be applied for the simultaneous assay of many samples. The activity of GTP cyclohydrolase I was measured in several rat tissues. For example, the enzyme activity in rat striatum (n = 5) was 13.7 +/- 1.5 pmol/mg protein per hour (mean +/- SE), and agreed well with those obtained by high-performance liquid chromatography with fluorescence detection. The activity in the autopsy human brains (caudate nucleus) was measured by this new method for the first time. The activity in the caudate nucleus from parkinsonian patients (n = 6) was 0.82 +/- 0.56 pmol/mg protein per hour which was significantly lower than the control value, 4.22 +/- 0.43 pmol/mg protein per hour (n = 10).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3706734     DOI: 10.1016/0003-2697(86)90537-3

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  4 in total

1.  Immunocytochemical localization of GTP cyclohydrolase I in the brain, adrenal gland, and liver of mice.

Authors:  I Nagatsu; H Ichinose; M Sakai; K Titani; M Suzuki; T Nagatsu
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  Blockade of tetrahydrobiopterin synthesis protects neurons after transient forebrain ischemia in rat: a novel role for the cofactor.

Authors:  S Cho; B T Volpe; Y Bae; O Hwang; H J Choi; J Gal; L C Park; C K Chu; J Du; T H Joh
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

3.  Bridging the gaps in secondary fracture prevention at a single center in Pakistan-compliance with the IOF best practice framework.

Authors:  Sibtain Ahmed; Nawazish Zehra; Shahryar Noordin; Anum Sadruddin; Aysha Habib Khan
Journal:  Arch Osteoporos       Date:  2021-10-26       Impact factor: 2.617

Review 4.  Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms.

Authors:  Sylvie Vancassel; Lucile Capuron; Nathalie Castanon
Journal:  Front Neurosci       Date:  2018-07-24       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.